Tigecycline
Showing 1 - 25 of 107
Blood Coagulation Disorder Trial
Not yet recruiting
- Blood Coagulation Disorder
- (no location specified)
Jan 16, 2023
Carbapenem-resistant Enterobacteriaceae Trial in Ratchathewi (Collect blood sample)
Recruiting
- Carbapenem-resistant Enterobacteriaceae
- Collect blood sample
-
Ratchathewi, Bangkok, ThailandPhramongkutklao Hospital
Sep 17, 2023
Carbapenem Resistant Klebsiella Pneumoniae Trial in Ratchathewi (Dose-adjustment by PKPD)
Recruiting
- Carbapenem Resistant Klebsiella Pneumoniae
- Dose-adjustment by PKPD
-
Ratchathewi, Bangkok, ThailandPhramongkutklao Hospital
May 7, 2023
Elderly Infection Trial in Jinan (biapenem,meropenem,piperacillin and tazobactam,tigecycline,levofloxacin.etc)
Recruiting
- Elderly Infection
- biapenem,meropenem,piperacillin and tazobactam,tigecycline,levofloxacin.etc
-
Jinan, Shandong, ChinaWei Zhao
Jun 17, 2022
Tigecycline-based Therapy and Polymyxin B-based Therapy in ICU
Unknown status
- Tigecycline
- +2 more
-
Changsha, Hunan, ChinaXiangya Hospital of Central south university
Jul 19, 2021
Antibiotic Therapy for Infectious Diseases
Recruiting
- Infectious Disease
- Tigecycline
-
Jinan, Shandong, ChinaWei Zhao
Jun 23, 2021
Microbial Disease Trial in Roskilde (Tigecycline 50 MG, Placebo)
Recruiting
- Microbial Disease
- Tigecycline 50 MG
- Placebo
-
Roskilde, DenmarkZealand University Hospital
Sep 20, 2021
Endovascular Infection, Bone and Joint Infection, Skin and Soft Tissue Infection Trial in Morgantown (Amoxicillin,
Not yet recruiting
- Endovascular Infection
- +5 more
- Amoxicillin, amoxicillin-clavulanate, cefadroxil, cefpodoxime, cefalexin, ciprofloxacin, delafloxacin, doxycycline, levofloxacin, linezolid
- Ampicillin, ampicillin-sulbactam, cefazolin, cefepime, ceftaroline, ceftazidime, ceftazidime-avibactam, dalbavancin, daptomycin, ertapenem
-
Morgantown, West VirginiaWest Virginia University
Jul 24, 2023
Spontaneous Bacterial Peritonitis Trial in New Delhi (Imipenem, Tigecycline, GMCSF)
Unknown status
- Spontaneous Bacterial Peritonitis
- Imipenem
- +3 more
-
New Delhi, Delhi, IndiaInstitute of Liver and Biliary Sciences
Feb 14, 2021
Tigecycline in Patients Treated With ECMO
Unknown status
- Extracorporeal Membrane Oxygenation
- +2 more
-
Guangzhou, ChinaSouthern medical university Nanfang hospital
Jan 25, 2021
Surgical Site Infection Trial in Roma (Delafloxacin, Vancomycin, Linezolid)
Terminated
- Surgical Site Infection
- Delafloxacin
- +4 more
-
Roma, ItalyHospital Agostino Gemelli
Jan 25, 2022
Pulmonary Disease Due to Mycobacteria (Diagnosis) Trial in Worldwide (Amikacin, Tigecycline, Imipenem)
Recruiting
- Pulmonary Disease Due to Mycobacteria (Diagnosis)
- Amikacin
- +13 more
-
South Brisbane, Queensland, Australia
- +36 more
Sep 12, 2022
Appendicitis Trial in United States (Cefoxitin, Ertapenem, Moxifloxacin, Tigecycline, Ticarcillin-Clavulanic Acid; Metronidazole
Completed
- Appendicitis
- Cefoxitin, Ertapenem, Moxifloxacin, Tigecycline, Ticarcillin-Clavulanic Acid; Metronidazole plus Cefazolin, Cefuroxime, Ceftriaxone, Cefotaxime, Ciprofloxacin, or Levofloxacin
- Appendectomy
-
Sylmar, California
- +24 more
Sep 8, 2021
Carbapenem-Resistant Enterobacteriaceae Infection Trial in China (treatment with or without colistin)
Not yet recruiting
- Carbapenem-Resistant Enterobacteriaceae Infection
- treatment with or without colistin
-
Hefei, Anhui, China
- +13 more
Sep 20, 2023
Acute Leukemia Trial (Rifaximin with allogeneic stem cell transplant, Allogeneic stem cell transplant)
Not yet recruiting
- Acute Leukemia
- Rifaximin with allogeneic stem cell transplant
- Allogeneic stem cell transplant
- (no location specified)
Sep 21, 2023
Infection; Dialysis Catheter Trial in San Diego (NAC/Tigecycline/Heparin combination lock solution, Standard anticoagulant
Terminated
- Infection; Dialysis Catheter
- NAC/Tigecycline/Heparin combination lock solution
- Standard anticoagulant (Heparin or Citrate)
-
San Diego, CaliforniaUCSD Medical Center
Aug 15, 2019
Carbapenem-Resistant Enterobacteriaceae Infection, Bloodstream Infection Trial in Porto Alegre (Meropenem)
Terminated
- Carbapenem-Resistant Enterobacteriaceae Infection
- Bloodstream Infection
-
Porto Alegre, RS, Brazil
- +1 more
Aug 1, 2022
Nontuberculous Mycobacterial Lung Disease Trial in Shanghai (New regimen(BdqCfzLzd+XY))
Not yet recruiting
- Nontuberculous Mycobacterial Lung Disease
- New regimen(BdqCfzLzd+XY)
-
Shanghai, ChinaShanghai Pulmonary Hospital
Aug 8, 2022
Tygacil Drug Use Investigation
Completed
- Intra-Abdominal Infections
- Skin Disease, Infectious
- Tigecycline (Tygacil)
- (no location specified)
Jan 17, 2019
Carbapenem-Resistant Enterobacteriaceae Infection Trial in Jinan (CAZ/AVI plus Aztreonam, Conventional treatment)
Recruiting
- Carbapenem-Resistant Enterobacteriaceae Infection
- CAZ/AVI plus Aztreonam
- Conventional treatment
-
Jinan, Shandong, ChinaMingju Hao
Apr 29, 2023
Antibiotic Therapy Trial in Singapore (In vitro antibiotic combination testing (iACT))
Recruiting
- Antibiotic Therapy
- In vitro antibiotic combination testing (iACT)
-
Singapore, SingaporeAndrea Lay Hoon KWA (SGH)
Oct 7, 2021
End-Stage Renal Disease, Hemodialysis Catheter-associated Infection Trial in Houston (catheter lock solution consisting of
Completed
- End-Stage Renal Disease
- Hemodialysis Catheter-associated Infection
- catheter lock solution consisting of N-acetylcystein, tigecycline and heparin
-
Houston, Texas
- +2 more
Oct 7, 2019
Acinetobacter Baumannii-related Osteomyelitis: Clinical and
Completed
- Osteomyelitis
-
Sao Paulo, BrazilInstituto de Ortopedia e Traumatologia do Hospital das Clinicas
Apr 27, 2021
Antibiotic Resistant Infection Trial in Shanghai (Fosfomycin, Tigecycline, Polymyxin B)
Unknown status
- Antibiotic Resistant Infection
- Fosfomycin
- +2 more
-
Shanghai, Shanghai, ChinaShanghai 10th people's hospital
May 11, 2019
Community-Acquired Pneumonia, Antimicrobial Stewardship, Point-of-Care Testing Trial in United States (Rapid Diagnostic Testing,
Recruiting
- Community-Acquired Pneumonia
- +2 more
- Rapid Diagnostic Testing
- Pharmacist-led de-escalation
-
Weston, Florida
- +10 more
Jan 5, 2023